Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
Clinical trial NCT04368728 · COMPLETED
Trial details
- NCT number
- NCT04368728
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-29
- Primary completion
- 2023-02-10
- Enrollment
- 46969
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.